← Browse by Condition
Medical Condition
hematopoietic and lymphoid system neoplasm
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
NCT03471260 Phase 1, Phase 2
Recruiting
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
Enrollment
96 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06314672
Recruiting
Outreach Project to Connect Underrepresented Populations to Clinical Trials at Ohio State University, CUSP2CT Project Trial
Enrollment
208 pts
Location
United States
Sponsor
Ohio State University Comprehe...